# Study of Clinical Efficacy and Safety of Tosedostat in MDS

> **NCT02452346** · PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 12 (actual)

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Tosedostat

## Key facts

- **NCT ID:** NCT02452346
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-20
- **Primary completion:** 2017-10-25
- **Final completion:** 2017-10-25
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02452346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02452346, "Study of Clinical Efficacy and Safety of Tosedostat in MDS". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02452346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*